SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
There are about 100 single point mutations of copper, zinc superoxide dismutase 1 (SOD1) which are reported (http://alsod.iop.kcl.ac.uk/Als/index.aspx) to be related to the familial form (fALS) of amyotrophic lateral sclerosis (ALS). These mutations are spread all over the protein. It is well documented that fALS produces protein aggregates in the motor neurons of fALS patients, which have been found to be associated to mitochondria. We selected eleven SOD1 mutants, most of them reported as pathological, and characterized them investigating their propensity to aggregation using different techniques, from circular dichroism spectra to ThT-binding fluorescence, size-exclusion chromatography and light scattering spectroscopy. We show here that these eleven SOD1 mutants, only when they are in the metal-free form, undergo the same general mechanism of oligomerization as found for the WT metal-free protein. The rates of oligomerization are different but eventually they give rise to the same type of soluble oligomeric species. These oligomers are formed through oxidation of the two free cysteines of SOD1 (6 and 111) and stabilized by hydrogen bonds, between beta strands, thus forming amyloid-like structures. SOD1 enters the mitochondria as demetallated and mitochondria are loci where oxidative stress may easily occur. The soluble oligomeric species, formed by the apo form of both WT SOD1 and its mutants through an oxidative process, might represent the precursor toxic species, whose existence would also suggest a common mechanism for ALS and fALS. The mechanism here proposed for SOD1 mutant oligomerization is absolutely general and it provides a common unique picture for the behaviors of the many SOD1 mutants, of different nature and distributed all over the protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1999) · Choice Reviews Online · doi:10.5860/choice.37-0940 · Cited by 14,314
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“As in the other neurodegenerative diseases, it appears unlikely that the visible SOD1-containing inclusions themselves are toxic; rather their presence suggests that smaller, soluble high molecular weight oligomeric precursor species containing SOD1 are being generated in vivo [11].”
BackgroundFridovich (1978) · doi:10.1126/science.210504 · Cited by 3,329 · cited 1×
“Its functional role is that of catalyzing the dismutation of superoxide radical to dioxygen and hydrogen peroxide [12,13].”
BackgroundToxic Proteins in Neurodegenerative Disease
Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002) · Science · doi:10.1126/science.1067122 · Cited by 1,251 · cited 1×
“feature of many neurological disorders such as Huntington’s, Alzheimer’s and Parkinson’s diseases [9].”
BackgroundAggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1
Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.281.5384.1851 · Cited by 1,228 · cited 1×
“The finding of proteinaceous aggregates containing SOD1 in motor neurons of postmortem fALS patients and transgenic mice was therefore a major advance in the field since it suggested that aggregation of SOD1 is related to the pathology of SOD1-linked fALS [10].”
BackgroundUNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185 · cited 3×
“paralysis [1].”
COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS
Valentine, J. S., Doucette, P. A., & Zittin Potter, S. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161647 · Cited by 785 · cited 1×
“zinc and copper ions, disulfide bond formation, and dimerization [3,14,15].”
BackgroundSelf-citationThe binding of thioflavin-T to amyloid fibrils: localisation and implications
Krebs, M. R. H., Bromley, E. H. C., & Donald, A. M. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2004.08.002 · Cited by 754 · cited 2×
“Oligomerization was shown to occur through a combination of oxidation of Cys 6 and Cys 111 and formation of amyloid-like interactions between beta strands, as judged by the ability of the oligomers to bind the amyloid-binding dye thioflavin T (ThT), a benzothiazole dye that exhibits increases in fluorescence intensity…”
Background
Cited by
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Barber, S. C., & Shaw, P. J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.018 · Cited by 617
Molecular targets of oxidative stress
Avery, S. V. (2011) · Biochemical Journal · doi:10.1042/bj20101695 · Cited by 474
Recent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274
“Structural and dynamic aspects related to oligomerization of SOD1 and its mutants have provided better insight into SOD1 pathway in relation to fALS (Banci et al. 2008, 2009).”
BackgroundMitochondrial quality control: An integrated network of pathways
Fischer, F., Hamann, A., & Osiewacz, H. D. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.02.004 · Cited by 248
Mitochondrial dysfunction in ALS
Cozzolino, M., & Carrì, M. T. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.06.003 · Cited by 240
“Apo- wild type and mutant SOD1 share an aberrant conformation and a tendency to oligomerize in vitro (Banci et al., 2008) and motor neurons in the lumbosacral spinal cord of some sporadic ALS patients contain an aberrant wild-type SOD1 species functionally equivalent to mutant SOD1 in its ability…”
BackgroundOxidative stress and neurodegeneration: the involvement of iron
Carocci, A., Catalano, A., Sinicropi, M. S., & Genchi, G. (2018) · BioMetals · doi:10.1007/s10534-018-0126-2 · Cited by 181
Aggregation of Copper–Zinc Superoxide Dismutase in Familial and Sporadic ALS
Chattopadhyay, M., & Valentine, J. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2536 · Cited by 163
“Since oligomerization required the presence of the two nondisulfide cysteines was inhibited by reducing agents, the mechanism likely involves oxidation of these cysteine residues to form intermolecular disulfide crosslinks (4, 7).”
Self-citationThe role of the Wnt canonical signaling in neurodegenerative diseases
Libro, R., Bramanti, P., & Mazzon, E. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.024 · Cited by 163
SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
Tafuri, F., Ronchi, D., Magri, F., Comi, G. P., & Corti, S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00336 · Cited by 162
“SOD1 misfolding seems to be related to different post translational mechanisms, involving disulfide bridge formation (Karch et al., 2009; Kawamata and Manfredi, 2010), incorrect C6 and C111 bond (Niwa et al., 2007) and loss of metal ion binding (Banci et al., 2008).”
BackgroundNonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis
Proctor, E. A., Fee, L., Tao, Y., Redler, R. L., Fay, J. M., Zhang, Y., Lv, Z., Mercer, I. P., Deshmukh, M., Lyubchenko, Y. L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516725113 · Cited by 131
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Cohen, J., Mathew, A., Dourvetakis, K. D., Sanchez-Guerrero, E., Pangeni, R. P., Gurusamy, N., Aenlle, K. K., Ravindran, G., Twahir, A., Isler, D., et al. (2024) · Cells · doi:10.3390/cells13060511 · Cited by 103
“Cu/Zn superoxide dismutase (SOD1) was the first causative gene identified to harbor mutations linked to ALS [201].”
BackgroundSelective Autophagy Receptors in Neuronal Health and Disease
Conway, O., Akpinar, H. A., Rogov, V. V., & Kirkin, V. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.013 · Cited by 75
Mice deficient in NRROS show abnormal microglial development and neurological disorders
Wong, K., Noubade, R., Manzanillo, P., Ota, N., Foreman, O., Hackney, J. A., Friedman, B. A., Pappu, R., Scearce-Levie, K., & Ouyang, W. (2017) · Nature Immunology · doi:10.1038/ni.3743 · Cited by 71
Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway
Nassif, M., Matus, S., Castillo, K., & Hetz, C. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2991 · Cited by 60
Metadata
- Authors
- Banci, L., Bertini, I., Boca, M., Girotto, S., Martinelli, M., Valentine, J. S., & Vieru, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-02-27
- Volume
- 3
- Issue
- 2
- Pages
- e1677
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2046002256
- Cited by
- 191
- References
- 28
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.